DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Doxil (Doxorubicin) - Interstitial Lung Disease - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Interstitial Lung Disease (10)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Doxil (Doxorubicin) where reactions include interstitial lung disease. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Doxil side effects in 85 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-30

Patient: 85 year old male, weighing 82.1 kg (180.6 pounds)

Reactions: Diabetes Mellitus, Oral Candidiasis, Interstitial Lung Disease, Acute Respiratory Distress Syndrome, Blood Creatinine Increased, Blood Urea Increased, Vomiting, Blood Chloride Decreased, Aortic Calcification, Atrial Fibrillation, Pancytopenia, Hyponatraemia, Mitral Valve Calcification, Brain Natriuretic Peptide Increased, Pernicious Anaemia, Dehydration, Mitral Valve Incompetence, Hypothyroidism, Asthenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Revlimid
    Dosage: 10 mg/daily/po
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-01-31
    End date: 2011-02-13

Decadron
    Dosage: 40 mg/wky/
    Indication: Multiple Myeloma
    Start date: 2011-01-31
    End date: 2011-02-10

Doxil
    Dosage: 8 mg
    Indication: Multiple Myeloma
    Start date: 2011-01-31
    End date: 2011-02-10

Velcade
    Dosage: 2 mg
    Indication: Multiple Myeloma
    Start date: 2011-01-31
    End date: 2011-02-13

Other drugs received by patient: Procrit; Aspirin; Neurontin; Zometa; Ciprofloxacin; Thioctic Acid; Synthroid; Dflucan; Calcium (Unspecified); Levoxyl; Acyclovir



Possible Doxil side effects in female

Reported by a pharmacist from Japan on 2012-04-10

Patient: female, weighing 57.0 kg (125.4 pounds)

Reactions: Hepatic Function Abnormal, Restlessness, Disseminated Intravascular Coagulation, Pancytopenia, Pyrexia, Fatigue, Malaise, Cardiac Failure, Interstitial Lung Disease, Dehydration, Bone Marrow Failure, Blood Pressure Decreased, Decreased Appetite, Anuria, Deep Vein Thrombosis

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Doxil
    Start date: 2010-11-24
    End date: 2010-11-24

Doxil
    Start date: 2010-11-24
    End date: 2010-11-24

Doxil
    Indication: Malignant Peritoneal Neoplasm
    Start date: 2010-12-22
    End date: 2010-12-22

Doxil
    Indication: Ovarian Cancer Recurrent
    Start date: 2010-12-22
    End date: 2010-12-22

Cisplatin W / Docetaxel
    Indication: Malignant Peritoneal Neoplasm

Cyclophosphamide
    Indication: Malignant Peritoneal Neoplasm

Zosyn
    Indication: Interstitial Lung Disease
    Start date: 2011-01-14
    End date: 2011-02-06

Minocycline Hydrochloride
    Indication: Infection
    Start date: 2011-01-29
    End date: 2011-01-31

Minocycline Hydrochloride
    Indication: Pyrexia
    Start date: 2011-01-29
    End date: 2011-01-31

Taxotere
    Indication: Malignant Peritoneal Neoplasm

Other drugs received by patient: Methycobal; Futhan; Recomodulin; Norvasc; Elaspol; Pentamidine Isethionate; Gosha-Jinki-GAN; Bactrim; Solu-Medrol; Zithromax; Predopa; Dalteparin Sodium; Reminaron; Bactrim; Solu-Medrol; Solu-Medrol; Mucosta; DAI-Kenchu-TO; Futhan; Dalteparin Sodium; Prodif; Humulin R; Magnesium Oxide; Midazolam HCL; Midazolam HCL; Vancomycin Hydrochloride; Pentamidine Isethionate; Predopa; Vancomycin Hydrochloride; Dalteparin Sodium; Prednisolone; Concentrated Human Blood Platelets



Possible Doxil side effects in female

Reported by a physician from Japan on 2012-04-10

Patient: female, weighing 51.0 kg (112.2 pounds)

Reactions: Ovarian Cancer Recurrent, Interstitial Lung Disease

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Doxil
    Dosage: cycle 1
    Start date: 2009-06-03
    End date: 2009-06-03

Docetaxel
    Dosage: 3 cycles completed
    End date: 2009-03-01

Docetaxel
    Dosage: 5 cycles completed
    Indication: Ill-Defined Disorder
    End date: 2008-11-13

Doxil
    Dosage: cycle 2
    Indication: Ovarian Cancer Recurrent
    Start date: 2009-07-01
    End date: 2009-07-01

Gemcitabine
    Dosage: 3 cycles completed
    Indication: Ill-Defined Disorder
    End date: 2009-03-24

Other drugs received by patient: Decadron; Ramosetron Hydrochloride; Thiamine Monophosphate Disulfide; Decadron; Decadron; Astomin; Azunol



Possible Doxil side effects in female

Reported by a physician from Japan on 2012-04-10

Patient: female, weighing 52.0 kg (114.4 pounds)

Reactions: Ovarian Cancer Recurrent, Interstitial Lung Disease

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Doxil
    Dosage: cycle 1
    Start date: 2009-06-12
    End date: 2009-06-12

Doxil
    Dosage: cycle 2
    Start date: 2009-07-10
    End date: 2009-07-10

Doxil
    Dosage: cycle 4
    Start date: 2009-09-04
    End date: 2009-09-04

Doxil
    Dosage: cycle 3
    Indication: Ovarian Cancer Recurrent
    Start date: 2009-08-07
    End date: 2009-08-07

Other drugs received by patient: Decadron; Decadron; Gran; Daio-Kanzo-TO; Azunol; Decadron; Decadron; Sunrythm; Decadron; Thiamine Monophosphate Disulfide; Thiamine Monophosphate Disulfide; Meiact; Decadron; Decadron; Thiamine Monophosphate Disulfide; Gemcitabine Hydrochloride; Decadron; Ramelteon; Thiamine Monophosphate Disulfide; Zolpidem; Decadron; Decadron; Banan; Ramelteon; Ramelteon; Ramelteon



Possible Doxil side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2011-11-23

Patient: male

Reactions: Pneumocystis Jiroveci Pneumonia, Interstitial Lung Disease

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Revlimid
    Administration route: Oral
    Start date: 2010-09-27
    End date: 2011-07-01

Doxil
    Indication: Product Used FOR Unknown Indication

Revlimid
    Administration route: Oral
    Indication: Multiple Myeloma
    End date: 2011-08-01

Decadron
    Indication: Product Used FOR Unknown Indication

Velcade
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Lasix; Prednisone TAB; Coreg; Flonase; Zometa; Ondansetron; Potassium Chloride; Prochlorperazine; Protonix; Vicodin; Fluconazole; Lovenox; Mepron; Ativan; Gabapentin



Possible Doxil side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2011-11-18

Patient: male

Reactions: Pneumocystis Jiroveci Pneumonia, Interstitial Lung Disease

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Revlimid
    Administration route: Oral
    Indication: Multiple Myeloma
    End date: 2011-08-01

Revlimid
    Administration route: Oral
    Start date: 2010-09-27
    End date: 2011-07-01

Velcade
    Indication: Product Used FOR Unknown Indication

Decadron
    Indication: Product Used FOR Unknown Indication

Doxil
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Potassium Chloride; Ondansetron; Flonase; Gabapentin; Lovenox; Coreg; Ativan; Mepron; Prednisone TAB; Protonix; Lasix; Prochlorperazine; Vicodin; Fluconazole; Zometa



Possible Doxil side effects in female

Reported by a physician from Japan on 2011-10-28

Patient: female, weighing 53.0 kg (116.6 pounds)

Reactions: Interstitial Lung Disease, Ovarian Cancer

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Doxil
    Dosage: cycle 1
    Indication: Ovarian Cancer
    Start date: 2010-06-29
    End date: 2010-06-29

Doxil
    Dosage: cycle 1
    Indication: Malignant Ascites
    Start date: 2010-06-29
    End date: 2010-06-29

Other drugs received by patient: Aldactone; Lasix; Etodolac; Magmitt; Pursennid; Betamethasone



Possible Doxil side effects in 71 year old female

Reported by a physician from Japan on 2011-10-24

Patient: 71 year old female

Reactions: Interstitial Lung Disease

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Doxil
    Dosage: cycle 2
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-09-09
    End date: 2011-09-09

Doxil
    Dosage: cycle 1
    Start date: 2011-07-01
    End date: 2011-07-01



Possible Doxil side effects in female

Reported by a physician from Japan on 2011-10-21

Patient: female

Reactions: Interstitial Lung Disease

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Doxil



Possible Doxil side effects in female

Reported by a pharmacist from Japan on 2011-10-14

Patient: female, weighing 47.0 kg (103.4 pounds)

Reactions: Stomatitis, Nausea, Interstitial Lung Disease, Constipation, Ulcer, Blister

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Doxil
    Dosage: cycle 1
    Indication: Ovarian Cancer Recurrent
    Start date: 2010-05-12
    End date: 2010-05-12

Doxil
    Dosage: cycle 4
    Start date: 2011-03-01
    End date: 2011-03-01

Doxil
    Dosage: cycle 2

Doxil
    Dosage: cycle 4
    Start date: 2010-08-03
    End date: 2010-08-03

Doxil
    Dosage: cycle 3

Other drugs received by patient: Dexaltin; Oxycontin; Ramelteon; Dexaltin; Loxonin; Ramelteon; Orgadrone; Orgadrone; Etodolac

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017